Publikation: Solcoseryl prevents inflammatory and hypoxic but not toxic liver damage in rodents
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Solcoseryl is a non-toxic, low-molecular-weight fraction of blood from veal calves, which is in clinical use against hypoxic conditions frequently associated with chronic inflammation. The pharmacodynamic actions of this haemo-dialysate were studied in different types of liver damage, including hepatic lesions inducedin vivo in mice by direct hepatotoxins or by endotoxin plus galactosamine. The isolated liver was perfused under hypoxic conditions. In addition,in vitro experiments with Kupffer cell/hepatocyte cocultures were carried out. Solcoseryl proved to be effective in protecting against endotoxin-induced liver damagein vivo. Perfusion with Solcoseryl reduced hypoxic liver damage in thein situ perfused mouse liver. In thein vitro model, the preparation prevented endotoxin-induced lesions, but not xenobiotic-induced toxic lesions. In line with these findings, Solcoseryl inhibited the endotoxin-inducible release of tumour necrosis factor-α from isolated Kupffer cells. This cytokine is known to be deleterious in several inflammatory pathomechanisms including endotoxin-induced hepatic lesions. It is concluded that Solcoseryl interacts with specific endogenous cytotoxicity mechanisms.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
HARTUNG, Thomas, Marcel LEIST, Gisa TIEGS, Werner BASCHONG, Albrecht WENDEL, 1991. Solcoseryl prevents inflammatory and hypoxic but not toxic liver damage in rodents. In: Inflammopharmacology. Springer. 1991, 1(1), pp. 49-60. ISSN 0925-4692. eISSN 1568-5608. Available under: doi: 10.1007/BF02735461BibTex
@article{Hartung1991Solco-51308, year={1991}, doi={10.1007/BF02735461}, title={Solcoseryl prevents inflammatory and hypoxic but not toxic liver damage in rodents}, number={1}, volume={1}, issn={0925-4692}, journal={Inflammopharmacology}, pages={49--60}, author={Hartung, Thomas and Leist, Marcel and Tiegs, Gisa and Baschong, Werner and Wendel, Albrecht} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/51308"> <dc:contributor>Hartung, Thomas</dc:contributor> <dc:creator>Hartung, Thomas</dc:creator> <dc:contributor>Wendel, Albrecht</dc:contributor> <dcterms:abstract xml:lang="eng">Solcoseryl is a non-toxic, low-molecular-weight fraction of blood from veal calves, which is in clinical use against hypoxic conditions frequently associated with chronic inflammation. The pharmacodynamic actions of this haemo-dialysate were studied in different types of liver damage, including hepatic lesions inducedin vivo in mice by direct hepatotoxins or by endotoxin plus galactosamine. The isolated liver was perfused under hypoxic conditions. In addition,in vitro experiments with Kupffer cell/hepatocyte cocultures were carried out. Solcoseryl proved to be effective in protecting against endotoxin-induced liver damagein vivo. Perfusion with Solcoseryl reduced hypoxic liver damage in thein situ perfused mouse liver. In thein vitro model, the preparation prevented endotoxin-induced lesions, but not xenobiotic-induced toxic lesions. In line with these findings, Solcoseryl inhibited the endotoxin-inducible release of tumour necrosis factor-α from isolated Kupffer cells. This cytokine is known to be deleterious in several inflammatory pathomechanisms including endotoxin-induced hepatic lesions. It is concluded that Solcoseryl interacts with specific endogenous cytotoxicity mechanisms.</dcterms:abstract> <dc:language>eng</dc:language> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:contributor>Tiegs, Gisa</dc:contributor> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:contributor>Baschong, Werner</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:issued>1991</dcterms:issued> <dc:creator>Tiegs, Gisa</dc:creator> <dc:creator>Leist, Marcel</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-12T09:49:53Z</dc:date> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:contributor>Leist, Marcel</dc:contributor> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:title>Solcoseryl prevents inflammatory and hypoxic but not toxic liver damage in rodents</dcterms:title> <dc:creator>Wendel, Albrecht</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-12T09:49:53Z</dcterms:available> <dc:creator>Baschong, Werner</dc:creator> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/51308"/> <dc:rights>terms-of-use</dc:rights> </rdf:Description> </rdf:RDF>